Deals Of The Week: GSK/Abbott, AZ/Merck, Bausch & Lomb/NicOX...
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com
You may also be interested in...
Branded drugs may earn only a fraction of Watson's generics, but firm sees overlapping opportunity in urology and women's health care.
The U.S. subsidiary of Shionogi acquired global development and marketing rights to QuatRx Pharmaceuticals' selective estrogen receptor modulator ospemifene, building on the company's sexual medicine and women's health portfolio
The Outsiders: Restructuring shows small biotechs' value in building Big Pharma's pipeline, says Targacept CEO Donald deBethizy.